Scientific Program - Sunday 12 May

Print
 
 
Sunday 12 April, 2019
HALL A
09:00-10:30
Chairs:


09:00-09:15
09:15-09:30
09:30-09:45


09:45-10:00
10:00-10:15
10:15-10:30
Session 7 | Therapeutic Target and New Options in Diabetes
Wang Yangang
, China, Su Benli, China and Ralph DeFronzo, USA

Should we change the A1C target in newly diagnosed patients?
Asia: Zhu Dalong, China
Rest of the World: Paolo Pozzilli, Italy
Discussion

Will dual agnostics (GLP1/Glucagon) provide the pharmalogic treatment for obesity and diabetes?
Asia: Guo Lixin, China
Rest of the World: Ralph DeFronzo, USA
Discussion
HALL B
09:00-10:30
Chairs:


09:00-09:15
09:15-09:30
09:30-09:45


09:45-10:00
10:00-10:15
10:15-10:30
Session 8 | Benefits of Body Weight Control
Wang Weiqing, China, Li Yanbing, China and Abdelmajid Chraibi, Morocco

Does non bariatric reduction in weight improve CVO in T2D patients?
Asia: Sou Dajin, China
Rest of the World: Luc Van Gaal, Belgium
Discussion

Should we reduce weight in elderly T2D patients?
Asia: Shi Yongquan, China
Rest of the World: Abdelmajid Chraibi, Morocco
Discussion
HALL C
09:00-10:30
Chairs:


09:00-09:15
09:15-09:30
09:30-09:45


09:45-10:00
10:00-10:15
10:15-10:30
Session 9 | Monitoring Blood Pressure and LDL
Peng Yongde
, China, Chen Bing, China and Ehud Grossman, Israel

Should we constantly monitor 24 b/p in patients with hypertension?
Asia: Shi Lixin, China
Rest of the World: Ehud Grossman, Israel
Discussion

Is LDL still the best lipid predictor for cardiovascular patients?
Asia: Yan Li, China
Rest of the World: Domenico Accili, USA
Discussion
 
10:30-10:50
VISIT EXHIBITS & COFFEE BREAK
10:50-11:50 INDUSTRY SPONSORED SYMPOSIA J-L  
11:50-12:00  LUNCH BOX PICK UP 
12:00-13:00 INDUSTRY SPONSORED SYMPOSIA M-O 
HALL A
13:00-14:30
Chairs:


13:00-13:15
13:15-13:30
13:30-13:45


13:45-14:00
14:00-14:15
14:15-14:30
Session 10 | Preservation of Beta Cell Funtion and Reverse of Diabetes
Xhang Qiao
, China, Shan Zhongyan, China and Ralph DeFronzo, USA

Is beta cell preservation feasible in type 2 diabetes?
Asia: Wang Guang, China
Rest of the World: Antonio Ceriello, Italy
Discussion

Is diabetes reversible or not?
Asia: Hong Jie, China
Rest of the World: Ralph DeFronzo, USA
Discussion
HALL B
13:00-14:30
Chairs:


13:00-13:15
13:15-13:30
13:30-13:45


13:45-14:00
14:00-14:15
14:15-14:30
Session 11 | Controversies of Antidiabetic Therapy
Gu Wei
, China, Tang Xulei, China and Philip Home, UK

Should we turn to new therapies in most T2D despite the cost?
Asia: Ji Linong, China
Rest of the World: Eberhard Standl, Germany
Discussion

Is Insulin the best injectable therapy?
Asia: Ji Qiuhe, China
No: Abdelmajid Chraibi, Morocco
Discussion

 HALL C

13:00-14:30
Chairs:


13:00-13:15
13:15-13:30
13:30-13:45


13:45-14:00
14:00-14:15
14:15-14:30
Session 12 | The Goal of Antihypertensive therapy and restriction of sodium
Hong Tianpei
, China, Wang Guixia, China and Domenico Accili, USA

Should we aim at blood pressure <130 in diabetic subjects?
Yes: Ehud Grossman, Israel
No: Bi Yufang, China
Discussion

Is sodium restriction effective for lowering blood pressure?
Asia: Zhao Wenhua, China
Rest of the World: Ehud Grossman, Israel
Discussion
 
14:30-14:45  VISIT EXHIBITS & COFFEE BREAK
PLENARY HALL
14:45-15:15
Chair:
Session 13 | The Importance of Triglyceride Management in Type 2 Diabetic Patients
Wang Weiqing
, China

Speaker: Ji Qiuhe, China
PLENARY HALL
15:15-16:45
Chair:

Session 14 | CREDENCE Study Share
Wang Weiqing
, China

Speaker: Ji Linong, China

 PLENARY HALL

16:45-17:45 
Chair:
Closing Session | How to Submit a Paper
Ning Guang
, China

Speaker: Richard Donnelly, UK - Editor in Chief, Diabeters, Obesity and Metabolism

 PLENARY HALL

17:45-18:05
Chairs:
Closing Session | Key Note Lecture
Ning Guang
, China and Itamar Raz, Israel

Diabetes prevention and early treatment: Ralph DeFronzo, USA
18:05-18:15  Closing Ceremony